IMM-H014
- Generic Name
- IMM-H014
To Evaluate the Safety, Tolerability, Pharmacokinetics and Food Effects of IMM-H014 in Healthy Subjects
Phase 1
Recruiting
- Conditions
- Nonalcoholic Steatohepatitis (NASH)
- Interventions
- First Posted Date
- 2024-01-22
- Last Posted Date
- 2025-04-11
- Lead Sponsor
- Changchun Intellicrown Pharmaceutical Co. LTD
- Target Recruit Count
- 138
- Registration Number
- NCT06216041
- Locations
- 🇨🇳
The first Bethune hospital of Jilin University, Changchun, Jilin, China
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath